Sarah Cannon Research Institute/Tennesee Oncology

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies	B-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, cardiovascular disorder, diffuse large B-cell lymphoma, follicular lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, marginal zone lymphoma, mature T-cell and NK-cell non-Hodgkin lymphoma, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 1	2025-02-24		NCT04072458

Clinical trials